Why Dow Jones' Merck Looks Poised To Edge Out Bristol In Lung Cancer [Investor's Business Daily]
Merck & Company, Inc. (new) (MRK)
Last merck & company, inc. (new) earnings: 4/28 06:45 am
Check Earnings Report
US:NYSE Investor Relations:
investors.merck.com/home/default.aspx
Company Research
Source: Investors Business Daily
Related news 11:09 AM ET Johnson & Johnson nudged its 2018 sales guidance higher Tuesday as demand for cancer drugs surged in the first quarter,... Premarket Trading: Blue Chips, Netflix Power Up; China Adds Tariffs Dow Hits Resistance At 50-Day As Apple Stock Moves Higher Bristol Topples After Merck Treatment Outperforms It In Lung Cancer Tests Can This Smaller Biotech Actually Rival Merck, Bristol In Cancer Drugs? NewLink Shares Bite The Dust After Merck-Incyte Melanoma Failure Stock Market Futures Rally After Syria Mission 'Accomplished'; These 5 S&P 500 Stocks Have Big News Dow Jones Component Pfizer Isn't Interested In Bristol — Yet Exelixis Rebounds As Analyst Urges Investors To Buy Monday's Dip Shares of Dow Jones component Merck ( MRK ) popped Tuesday on an upgrade after its lung cancer treatment trounced a rival regimen from Bristol-Myers Squibb ( BMY ). Morgan Stanley analyst David Risinger now expects Merck to take the lion's
Show less
Read more
Impact Snapshot
Event Time:
MRK
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
---|---|---|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
Last Price | ||
VWAP | ||
High:
|
Max Up |
High:
|
Low:
|
Max Down |
Low:
|
%
|
Post news range |
%
|
|
Price change |
|
|
Price Change Percentage |
|
|
S&P 500 (SPX) |
|
%
|
Volume ratio |
%
|
Volume | ||
Ticks | ||
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
MRK alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
MRK alerts
High impacting Merck & Company, Inc. (new) news events
Weekly update
A roundup of the hottest topics
MRK
News
- Merck (MRK) Q1 2024 Earnings Call Transcript [Yahoo! Finance]Yahoo! Finance
- Merck Stock Gains On Its Blockbuster Cancer Drug Keytruda, Raises Annual Outlook [Yahoo! Finance]Yahoo! Finance
- Merck (MRK) Q1 Earnings Top, Cancer Drug Keytruda Boosts Sales [Yahoo! Finance]Yahoo! Finance
- Merck (MRK) Q1 Earnings: Taking a Look at Key Metrics Versus Estimates [Yahoo! Finance]Yahoo! Finance
- TME Pharma Publishes 2023 Financial Results and Provides Operating Update [Yahoo! Finance]Yahoo! Finance
MRK
Earnings
- 4/25/24 - Beat
MRK
Sec Filings
- 4/25/24 - Form 8-K
- 4/11/24 - Form ARS
- 4/11/24 - Form DEFA14A
- MRK's page on the SEC website